Výsledky vyhledávání - "Taylar A. Clark"

Akademický článek

Update to the study protocol for an implementation-effectiveness trial comparing two education strategies for improving the uptake of noninvasive ventilation in patients with severe COPD exacerbation

Autor: Mihaela S. Stefan, Penelope S. Pekow, Christopher M. Shea, Ashley M. Hughes, Nicholas S. Hill, Jay S. Steingrub, Mary Jo S. Farmer, Dean R. Hess, Karen L. Riska, Taylar A. Clark, Peter K. Lindenauer

Publikováno v: Trials, Vol 22, Iss 1, Pp 1-5 (2021)

Abstract Background There is strong evidence that noninvasive ventilation (NIV) improves the outcomes of patients hospitalized with severe COPD exacerbation, and NIV is recommended as the first-line therapy for these patients. Yet, several studies ha

Externí odkaz: https://doaj.org/article/635648ba407242f1838e0cacd6e52153

Zobrazit plný text záznamu

Exploring the Patient Experience with Noninvasive Ventilation: A Human-Centered Design Analysis to Inform Planning for Better Tolerance

Autor: Jill L. McCormick, Taylar A. Clark, Christopher M. Shea, Dean R. Hess, Peter K. Lindenauer, Nicholas S. Hill, Crystal E. Allen, MaryJo S. Farmer, Ashley M. Hughes, Jay S. Steingrub, Mihaela S. Stefan

Publikováno v: Chronic Obstr Pulm Dis

Background: This study brings a human-centered design (HCD) perspective to understanding the patient experience when using noninvasive ventilation (NIV) with the goal of creating better strategies to improve NIV comfort and tolerance. Methods: Using

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11888f4bd4ead67df5bb3ba095478035
https://pubmed.ncbi.nlm.nih.gov/35018753

Zobrazit plný text záznamu

Update to the study protocol for an implementation-effectiveness trial comparing two education strategies for improving the uptake of noninvasive ventilation in patients with severe COPD exacerbation

Publikováno v: Trials, Vol 22, Iss 1, Pp 1-5 (2021)
Trials

Background There is strong evidence that noninvasive ventilation (NIV) improves the outcomes of patients hospitalized with severe COPD exacerbation, and NIV is recommended as the first-line therapy for these patients. Yet, several studies have demons

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72d9f4ab4cc3f623c949861a9833bac6

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání